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was clearly localized to the endothelium of the peritubularEndothelin up-regulation and localization following renal is-
capillary network of the kidney.chemia and reperfusion.
Conclusions. Initial ET-1 gene up-regulation in the kidneyBackground. Endothelin (ET), a potent vasoconstrictor, is
occurs secondary to ischemia, but reperfusion most likely con-known to play a role in ischemic acute renal failure. Although
tributes to sustaining this up-regulation. The marked increasepreproET-1 (ppET-1) mRNA is known to be up-regulated
of ET-1 in the peritubular capillary network suggests that ET-following ischemia/reperfusion injury, it has not been deter-
induced vasoconstriction may have a pathophysiological rolemined which component of the injury (ischemia or reperfusion)
in ischemic acute tubular necrosis.leads to initial gene up-regulation. Likewise, although ET-1
peptide expression has been localized in the normal kidney,
its expression pattern in the ischemic kidney has not been
determined. Therefore, the purpose of this study was twofold: Endothelin (ET), a 21-amino acid peptide, is the most(a) to determine whether ischemia alone or ischemia plus re-
potent vasoconstrictor discovered to date [1]. Shortlyperfusion is required for the up-regulation of ppET-1 mRNA
after its discovery in 1988, it was suggested that ET mightto occur, and (b) to localize ET-1 peptide expression following
ischemia in the rat kidney to clarify better the role of ET in be an important mediator of acute renal failure (ARF)
the pathophysiology of ischemia-induced acute renal failure. because of its intense vasoconstrictive properties [2].
Methods. Male Lewis rats underwent clamping of the right Several lines of evidence supporting this hypothesis have
renal vascular pedicle for either 30 minutes of ischemia (group
been reported. First, it was shown that exogenous ET1), 60 minutes of ischemia (group 2), 30 minutes of ischemia
infused into the kidney was able to decrease renal bloodfollowed by 30 minutes of reperfusion (group 3), or 60 minutes
of ischemia followed by three hours of reperfusion (group 4). flow and glomerular filtration rate (GFR) to create con-
The contralateral kidney acted as a control. ppET-1 mRNA ditions that can lead to ARF [3, 4]. Shibouta et al, using
up-regulation and ET-1 peptide expression were examined us- a rat model of bilateral renal artery occlusion, reported
ing the reverse transcription-polymerase chain reaction and
that in addition to renal dysfunction and histologic evi-immunohistochemistry, respectively.
dence of proximal tubular necrosis, there was a concomi-Results. Reverse transcription-polymerase chain reaction
tant rise in renal tissue levels of ET [5]. This establishedyielded a control (nonischemic) value of 0.6 6 0.2 densitometric
units (DU) of ppET-1 mRNA in the kidney. Group 1 levels a link between a stimulus known to cause ARF, namely
(30 min of ischemia alone) were 1.8 6 0.4 DU, a threefold ischemia/reperfusion (I/R) injury [6, 7], and a rise in ET
increase (P , 0.05). Group 2 levels (60 min of ischemia alone) production. Subsequently, several groups demonstratedincreased almost six times above baseline, 3.5 6 0.2 DU (P
that the administration of either monoclonal antibodies, 0.01), whereas both group 3 and group 4 (ischemia plus
to ET or ET receptor antagonists resulted in the im-reperfusion) did not experience any further significant in-
creases in mRNA levels (1.9 6 0.4 DU and 2.8 6 0.6 DU, provement of both renal function and renal histology in
respectively) beyond levels in group 1 or 2 animals subjected the setting of I/R injury [8–11].
to similar ischemic periods. ET-1 peptide expression in the With a role for ET in the pathophysiology of ARF
ischemic kidneys was significantly increased over controls and
now established [12–15], we became interested in clarify-
ing ET’s impact on ischemia-induced ARF. Although it
is known that renal I/R injury leads to an increasedKey words: ischemic renal failure, reperfusion injury, acute tubular
necrosis, gene up-regulation, vasoconstriction. synthesis of ET via ET gene up-regulation [16], no one
to date has determined whether the initial up-regulation
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of ischemia and reperfusion [4, 5, 16], despite the fact that
they can be examined as separate events. This distinction
could be important in order to determine the appropriate
timing of pharmacologic blockade of ET in clinical prac-
tice. Moreover, although the sites of ET synthesis have
been determined in the normal human kidney [17], local-
ization of ET production in the kidney following an is-
chemic insult has not been determined. Localizing the
Fig. 1. Polymerase chain reaction (PCR) primers for rat preproendo-actual sites of ET-1 expression following ischemia will thelin-1 gene. (A) Twenty-four nucleotide sequence for rat forward
help to explain further its role in the pathophysiology (upstream) primers of endothelin-1 (ET-1) cDNA representing posi-
tions 157 to 180 of the gene. (B) Twenty-three nucleotide sequenceof ARF.
for rat backward (downstream) primers of ET-1 cDNA, representingTherefore, the purpose of this study was twofold: (a) positions 536 to 514 of the gene. Both primers were analyzed in MacVec-
to determine whether ischemia alone or ischemia plus tor 5-1 using rat ET-1 cDNA sequence from National Biosciences Inc.
reperfusion is required for the up-regulation of prepro-
ET-1 (ppET-1) mRNA to occur by examining specific
periods of ischemia and reperfusion for their individual in liquid nitrogen and stored at 2708C until ready for
and combined influences on ET-1 gene up-regulation; analysis. Determination of ppET-1 mRNA followed a
and (b) to localize ET-1 peptide expression following method from Rhoten et al [18]. Briefly, 30 mg of tissue
ischemia in the rat kidney to clarify better the role of was homogenized in 600 ml of RNA lysis thiocyanate
ET in the pathophysiology of ischemia-induced ARF. lysate buffer (Quiagen Inc., Chatsworth, CA, USA) us-
ing a hand-held RNase-free tissue grinder (Tekmar Inc.,
Cincinnati, OH, USA). The homogenate was then centri-METHODS
fuged at 15,000 3 g in a microcentrifuge for three min-Model of renal ischemia and reperfusion
utes. Total RNA was then extracted from the superna-
Male Lewis rats, 250 to 300 g, were obtained from tant using the RNeasy total RNA kit from Quiagen. First
Harlan Sprague Dawley Inc. (Indianapolis, IN, USA) strand complementary DNA was synthesized with 1 mg
and were cared for in accordance with the Case Western total RNA as a template for ET analysis and a down-
Reserve University Animal Research Center regula- stream primer of the rat ppET-1 gene (National Biosci-
tions. All animals were anesthetized with an intraperito- ences Inc., Plymouth, MN, USA; Fig. 1B). Glyceralde-
neal injection of sodium pentobarbital (50 mg/kg) and hyde 3-phosphate dehydrogenase (GAPDH) (0.1 mg)
underwent a midline laparotomy to expose the right kid- was used as an internal control. A reverse transcription
ney. The right renal pedicle was dissected free from sur- reaction was performed (25 mm MgCl2, 10 3 PCR buffer
rounding tissues, and an atraumatic vascular clamp was II, 10 mm of each of the following: dATP, dCTP, dGTP,
placed across the renal artery, vein, and ureter for either and dTTP, 1 ml of murine leukemia virus reverse tran-
30 or 60 minutes of ischemia. To determine the effects scriptase, and 1 ml of RNase inhibitor) at 428C for 40
of ischemia alone on ET-1 gene expression, group 1 minutes. Next, PCR was performed by adding 25 mm
animals (N 5 5) underwent 30 minutes of ischemia with- MgCl2, 10 3 PCR buffer II, 0.75 ml of the upstream and
out reperfusion, and group 2 (N 5 9) underwent 60 downstream primers for rat ppET-1 (Fig. 1) or GAPDH
minutes of ischemia also without reperfusion. To deter- (sequences not shown), 0.5 ml of AmpliTaq DNA poly-
mine the additional impact of reperfusion on the same merase, and RNase free water to the prior reverse tran-
ischemic insults, group 3 animals (N 5 5) underwent 30 scription reaction mixture for two minutes at 958C (tem-
minutes of ischemia followed by 30 minutes of reperfu- plate melting step), 35 cycles of melting for one minute
sion, and group 4 (N 5 5) underwent 60 minutes of at 958C, annealing for one minute at 608C, extending for
ischemia followed by a three-hour period of reperfusion. one minute at 728C, and one final extension for seven
The contralateral kidney, which was not rendered ische- minutes at 728C. (Note that the reactions for ppET-1
mic in any of the test groups, acted as an internal control and GAPDH mRNA were carried out in separate micro-
for each animal. After the assigned treatment period was centrifuge tubes. This was not multiplex PCR.) Samples
completed, both the control and the ischemic kidney were then vacuum dried, separated on a 2% agarose
were removed and processed for further analysis. gel with 0.5 mg/ml ethidium bromide, and analyzed by
scanning densitometry using the National Institutes of
Reverse transcription-polymerase chain reaction Health Image program for the Macintosh computer.
analysis for ppET-1 mRNA
Immunohistochemical staining for ET-1Kidneys for reverse transcription-polymerase chain re-
action (RT-PCR) analysis of ppET-1 mRNA were dis- Five animals from group 2 (60 min of ischemia alone)
had both kidneys removed and coated in OCT-tissuesected free from surrounding tissue and were snap frozen
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TEK II (Miles Laboratories, Naperville, IL, USA).
These fresh samples were then frozen in liquid nitrogen
cooled 2-methylbutane and stored at 2708C. The kidneys
were sectioned at 5 mm on a cryostat, placed on slides,
and refrozen overnight. Immunohistochemical staining
was carried out according to the method of Rhoten et
al [18]. Briefly, thawed slides were fixed in acetone for 10
minutes and were then washed in Dulbecco’s phosphate-
buffered saline (DPBS). To block endogenous peroxi-
dases, the slides were washed in 60 ml of a 3% solution
of hydrogen peroxide, methanol, and distilled water for
20 minutes. Slides were again rinsed in DPBS. To block
nonspecific binding, the slides were washed with 10%
normal goat serum for 30 minutes. After a third DPBS
rinse, the slides were incubated with the primary anti-
body (mouse anti–ET-1 monoclonal antibody; QED Bio-
science, Plymouth, MN, USA) at 1:100 and 1:200 dilu-
tions in 1% normal goat serum in DPBS solution for
one hour. The slides were then incubated with the horse-
radish peroxidase-labeled secondary antibody (goat anti-
mouse IgG H 1 L antibody; Kirkegard and Perry Labo-
ratories Inc., Gaithersburg, MD, USA) at 1:100 and 1:200
dilutions for one hour. Slides were developed using a
diethylaminobenzidine solution, counterstained with
methyl green and were then dehydrated for mounting
in successive concentrations of ethanol (70%, 95%, and
100%) followed by xylene clearing. Following mounting
(Eukitt reagent; Calibrated Instruments, Inc., Haw-
thorne, NY, USA), photomicrographs were taken of all
slides with a Nikon Optiphot camera using Agfapan
ASA25 film with a green filter. All photos were exposed
and developed identically to allow semiquantitative com-
parisons of relative staining intensity.
Statistical analysis
Fig. 2. Results of the RT-PCR analysis of preproendothelin-1 (ppET-1)
Statistical analysis of our data was performed using mRNA levels. (A) Representative agarose gel demonstrating products
of PCR amplification of rat renal ppET-1 mRNA. Lane 1 denotes thethe InStat program for Macintosh computers obtained
molecular weight (MW) of known products for comparison to experi-from Graphpad Software (San Diego, CA, USA). The mental samples. Lane 2 denotes control (C) kidney—no ischemia. A
data presented are the mean 6 sem. P less than 0.05 is weak band representing ppET-1 is seen at 380 bp. Lane 3 shows ischemic
(I) kidney. Note the increased signal intensity in the 380 bp bandconsidered significant.
representing an increase in ppET-1 mRNA. Ischemia acts as a potent
stimulus to up-regulate ppET-1 mRNA. (B) Graph of the results of
scanning densitometry of the gel shown in A, demonstrating that theRESULTS mRNA produced was directly proportional to the amount of total input
RNA, verifying that the assay was linear and could be subjected toPreproET-1 mRNA levels
semiquantitative analysis. Symbols are (d) GAPDH; (j) ppET-1.
The purpose of these experiments was to determine
whether ischemia alone or ischemia plus reperfusion is
responsible for the initial up-regulation of ppET-1
mRNA. Therefore, a RT-PCR reaction was performed housekeeping gene to ensure that the up-regulation of
the ppET-1 gene was not simply a global gene up-regula-on total RNA extracted from the ischemic and control
(nonischemic) kidneys from all four experimental groups tion secondary to the ischemic injury. It also normalizes
all samples for differences in input RNA. The RT-PCRto isolate ppET-1 mRNA. A representative gel produced
from the control and ischemic kidney analysis (Fig. 2A) reaction was a linear assay, as seen in Figure 2B. In this
type of analysis, as the total amount of input RNA isclearly demonstrates two isolated bands: a 380 bp mRNA
product, representing ppET-1, and a second product at increased, the signal intensity of the corresponding gel
band increases. This allows semiquantitative analysis of452 bp, representing GAPDH. GAPDH acts as a
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Fig. 3. Densitometric analysis of rat renal
preproendothelin-1 mRNA following various
ischemia/reperfusion injuries. All values of
ppET-1 mRNA are expressed on the y-axis
in densitometric units (DU). (A) Kidneys ex-
posed to 30 minutes of ischemia (group 1)
demonstrated an increase in ppET-1 mRNA
three times above nonischemic controls (*P
, 0.05). Extending the ischemia time to 60
minutes increased the levels to almost sixfold
above baseline levels (**P , 0.01). Moreover,
the doubling of ppET-1 levels seen by increas-
ing the time of ischemia from 30 to 60 minutes
was also statistically significant (P , 0.05). (B)
Thirty minutes of ischemia plus 30 minutes of
reperfusion (group 3) essentially maintained
but did not lead to any significant increases in
the levels of ppET-1 mRNA when compared
with levels observed after 30 minutes of ische-
mia alone. Likewise (C), the mRNA levels of
ppET-1 following 60 minutes of ischemia with
180 minutes of reperfusion (group 4) did not
increase the levels of ppET-1 mRNA tran-
scription over levels achieved with 60 minutes
of ischemia alone. These studies implicate is-
chemia as the primary stimulus that initially
up-regulates the ppET-1 gene.
the stained gel bands to be performed. When we exam- In our second set of experiments, we wished to deter-
mine what additional impact the specific reperfusionined the gel bands from our various experimental groups,
utilizing densitometric analysis, we found the results that times we chose would add to ppET-1 mRNA synthesis.
Therefore, group 3 kidneys were exposed to 30 minutesare outlined in Figure 3.
PreproET-1 mRNA levels in normal rat kidneys were of ischemia followed by 30 minutes of reperfusion. This
experimental group serves two purposes: First, it allows0.6 6 0.2 densitometric units (DU). This represents the
baseline expression of ppET-1 mRNA in the rat kidney a direct comparison to our findings in group 1 (30 min
ischemia alone), and second, it represents an equivalent(refer to the 0-min time on Fig. 3A). In our first set of
experiments, which were designed to examine the impact amount of time (60 min total) when compared with group
2 (60-min ischemia alone). Group 3 treatment resultedthat ischemia alone has on ppET-1 mRNA transcription
levels, group 1 kidneys (exposed to 30 min of ischemia; in 1.9 6 0.4 DU of ppET-1 mRNA. Although this amount
of mRNA up-regulation is significant when comparedFig. 3A) exhibited a rise in ppET-1 mRNA levels to
1.8 6 0.4 DU. This rise represented a significant (P , with our controls (P , 0.05), it is not significantly differ-
ent from group 1 levels (1.8 6 0.4 DU; Fig. 3B). Finally,0.05) threefold increase in mRNA expression, indicating
that a minimal ischemic event without reperfusion can group 4 kidneys were exposed to a 60-minute period of
ischemia followed by a three-hour period of reperfusion.evoke a significant increase in ppET-1 mRNA transcrip-
tion. When we increased the kidney’s ischemic period The ppET-1 mRNA level in these kidneys was 2.8 6 0.6
DU (Fig. 3C). Again, although this level of expressionto 60 minutes (group 2; Fig. 3A), the mRNA levels in-
creased to 3.5 6 0.2 DU, (P , 0.01), almost six times was still almost six times that observed in normal kidneys,
it was not significantly different from the ppET-1 mRNAthat of control kidneys. Notably, when we compared
group 1 to group 2, the doubling of ppET-1 mRNA levels levels noted in group 2 (animals exposed to the same 60
min of ischemia without reperfusion).(1.8 6 0.4 DU to 3.5 6 0.2 DU), resulting from the
additional 30 minutes of ischemia, was also statistically
Localization of ET-1 expression insignificant (P , 0.05). This trend points to the obvious
the ischemic kidneyconcern of always minimizing the amount of time an
organ is exposed to ischemia in the controlled setting Endothelin-1 peptide expression has been localized
via immunohistochemistry to several areas in the normal(that is, clamp time in vascular surgery).
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Fig. 4. Photomicrographs demonstrating ET-1 peptide expression in the cortex of the rat kidney following ischemia. (A) Magnification (340) of
a kidney exposed to 60 minutes of ischemia. ET-1 expression is seen in the endothelium of the peritubular capillary network (arrows, dark reaction
product). (B) Magnification (340) of the normal (nonischemic) kidney of the same animal as in panel A. Minimal staining is present in portions
of the PTCN (arrows) surrounding the convoluted tubules. Control specimens were also tested with nonimmune serum in an ischemic kidney (C)
to illustrate that immunoreactivity was specific for ET-1. (D) Finally, a low-power (310) magnification) view of the ischemic treated kidney shows
the relatively universal expression of ET-1 in the PTCN throughout the cortex of the ischemic kidney (arrows point to a few of the many peritubular
capillaries expressing the ET-1 peptide).
kidney, including the endothelial lining of interlobular significant increases in basal ET-1 expression. In contrast
to the intensely stained capillaries, the ET-1 staining inand arcuate arteries, glomerular capillaries, and some
convoluted tubular epithelium [17]. However, the local- the cortical tubular epithelium of ischemic kidneys was
only slightly elevated or normal (Fig. 4A) when com-ization of ET-1 following an ischemic event has yet to be
reported. We postulated that because of the significant pared with controls. In addition, although not shown,
we did note typical staining for ET-1 in the glomerularincrease in ET-1 gene up-regulation that we found fol-
lowing ischemia, there would be a concomitant increase capillaries, interlobular and arcuate arteries, and veins
in both control and ischemic kidneys. However, thein ET-1 peptide expression. Because ischemic injury to
the kidneys primarily affects the renal tubules [6], we amount of ET-1 peptide present was not significantly
different between them.hypothesized that the tubular epithelium or surrounding
peritubular capillaries would be the primary site(s) of To demonstrate that the enhanced staining pattern
seen in the ischemic kidney truly represents ET-1 expres-this increased expression of ET-1 peptide. Indeed, we
found markedly higher levels of ET-1 peptide in the sion and not nonspecific antibody binding, the secondary
antibody was applied alone to ischemic kidney sections.endothelium of the cortical peritubular capillaries of is-
chemically injured kidneys (Fig. 4A, arrows, dark reac- As illustrated in Fig. 4C, there was essentially no staining
along the peritubular capillary network (PTCN), therebytion product) compared with low levels of peritubular
capillary ET-1 in control (nonischemic) kidneys (Fig. providing a negative control. In addition, a low-power
view of the ischemic kidney (Fig. 4D) illustrates that4B, arrows point to peritubular capillaries with minimal
staining). When we examined the medullary regions of the peritubular capillary expression of ET-1 takes place
uniformly throughout the cortex of the kidney followingthese same kidneys (not shown), we did not note any
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a global ischemic insult. Taken together, these results ischemia without any reperfusion. This peptide, once
produced, will bind with intense affinity to ET receptorsindicate that renal ischemia increases ET-1 peptide ex-
pression uniformly throughout the endothelium of the that have also been shown to be up-regulated or that at
least demonstrate increased affinity for ET in models ofcortical PTCN of the renal convoluted tubules, whereas
baseline medullary expression of ET-1 seems unaffected. ischemic ARF [21, 22]. This binding is significant and
considered by some almost irreversible [15, 23]. Thus, if
an ET receptor antagonist is not present and bound to
DISCUSSION
receptors prior to ET peptide formation, its effectiveness
Endothelin has been implicated as a contributing fac- as a potential agent to ameliorate vasoconstriction could
tor to ischemia-induced ARF [12–15]. The ET gene has be diminished. Therefore, because ET can be produced
been shown to be up-regulated by some of the same without reperfusion, ET antagonists may be most effec-
conditions seen in ARF, namely, hypoxia, hypotension, tive if given prior to the period of ischemia.
and I/R injury [4, 12–14, 16, 19]. Prior research has shown Endothelin’s role in the pathophysiological process of
that after 45 minutes of ischemia, followed by a two- ARF appears to be due primarily to its intense vasocon-
hour period of reperfusion, ppET-1 mRNA levels are strictive properties in the kidney. ET has classically been
increased [16]. However, this study does not clearly de- shown to cause vasoconstriction in both the afferent and
lineate which component of the injury—ischemia, reper- efferent arterioles of the glomerular tuft when adminis-
fusion, or a combination of the two—leads to the initial tered exogenously [3, 12, 24]. The vasoconstriction in
increase in ET synthesis. Our studies, in a rat model this area, along with the vasoconstriction sometimes seen
of ischemic ARF, clearly indicate that ischemia alone in the arcuate and interlobular arteries [17], has been
initiates ppET-1 mRNA up-regulation in the kidney. the postulated cause of ET-induced ARF. However, the
After only 30 minutes of ischemia without reperfusion, endogenous site(s) of ET-1 peptide expression in the
ppET-1 mRNA expression had almost tripled, and by kidney following an ischemic event has not yet been
60 minutes, it was over sixfold higher than control levels. clearly delineated. Determination of these sites could
When we added 30 minutes of reperfusion to a 30-minute further clarify the pathophysiology of ET-1 in ARF. Our
ischemic insult (group 3), we saw no significant increase immunohistochemical analysis of the kidney revealed
in ppET-1 levels. This trend was confirmed in our animals increased expression of ET-1 in the endothelium of the
exposed to 60 minutes of ischemia and three hours of cortical PTCN following an ischemic event. The PTCN
reperfusion; the ppET-1 mRNA levels were again not represents a continuation of the efferent arteriole of
statistically different from kidneys exposed to 60 minutes the glomerulus into a capillary bed that surrounds the
of ischemia alone. These data implicate ischemia as the convoluted tubules [25]. Expression of ET-1 in the vascu-
primary initiating stimulus for up-regulation of the lar bed, which directly surrounds and supplies the convo-
ppET-1 gene. Although we did not see continued in- luted tubules, has potentially significant consequences.
creases in ppET-1 mRNA in either of our reperfusion By restricting blood flow in the PTCN, ET-1 would cause
groups, the importance of the reperfusion injury cannot hypoxia to the adjacent cells lining the tubules. Pro-
be dismissed. ppET-1 mRNA expressed in vascular en- longed hypoxia from ongoing vasoconstriction in this
dothelial cells is very unstable and has a half-life of only bed could, in turn, lead to cell death and to the typical
approximately 15 minutes [20]. Therefore, unless reper- tubular epithelial sloughing seen in ATN. Consequently,
fusion continues to stimulate ppET-1 mRNA synthesis, our localization of ET-1 to the PTCN further supports
we should have seen a decrease in the ppET-1 mRNA the hypothesis of ET-1 as a possible pathophysiological
levels in group 4 after three hours of reperfusion, which factor in ATN.
we did not. Thus, reperfusion certainly plays a role in Supporting evidence for ET acting in the PTCN and
this injury cascade. causing ATN may also come from ET receptor antago-
Our novel observation that ischemia alone increases nist studies performed by others. The use of the ETA
ppET-1 mRNA synthesis may have important implica- receptor antagonist BQ 123 in both isolated perfused
tions in regard to the clinical use of pharmacologic block- kidney models and in vivo models of renal ischemia led
ade against ET-induced vasoconstriction. In the context to improved renal blood flow, preservation of GFR, and
of renal vascular surgery or kidney donation for trans- a significant decrease in proximal tubular necrosis [9–11].
plantation (both cadaveric and living related donors), The improvements in renal blood flow and GFR have
in which varying periods of ischemia to the kidney are previously been shown to be due to the effects that ET
anticipated, an ET receptor antagonist could be used to has on the preglomerular and postglomerular vascula-
protect against ARF and acute tubular necrosis (ATN). ture, namely the afferent and efferent arterioles of the
We have shown that ischemia alone is able to up-regulate glomerulus and the mesangial cells [12–14]. Endothelin,
the ppET-1 gene and that ET-1 peptide expression is by increasing afferent and efferent arteriolar resistance,
reduces nephron plasma flow rate and diminishes single-clearly present in the cortical PTCN after 60 minutes of
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nephron GFR [3, 12, 13]. Moreover, our localization of cal peritubular capillaries of the ischemic kidney. This
finding further implicates ET’s role in ischemia-inducedET to the postglomerular PTCN would be consistent
with the dramatic improvement in histology seen in the renal failure and may explain some of the impaired tubu-
lar function and tubular regeneration seen during theproximal tubules of kidneys treated with ET receptor
antagonists [8–11]. The presence of ET in the PTCN may various phases of ATN. In addition, we have shown that
the ppET-1 gene can be up-regulated by ischemia alone,also be related to other changes that typically accompany
ATN. For example, during ATN, tubular reabsorption but that reperfusion likely plays a role in sustaining ongo-
ing gene up-regulation in the time frames that we exam-of sodium decreases [6, 7]. Supporting a contributory role
for ET in this process are the reports that the infusion of ined. These points support the hypothesis that ET plays
an important role in the pathophysiology of ARF and/ET or endogenous ET production stimulated by I/R in-
jury has been shown to increase the fractional excretion or ATN. Moreover, they indicate that the most optimal
time to administer ET receptor antagonists may be priorof sodium [9, 10, 14, 15]. Conversely, the addition of a
nonselective ETA1B or a specific ETA receptor antagonist to the ischemic event.
led to increased net tubular reabsorption of sodium and
Reprint requests to James A. Schulak, M.D., University Hospitalsa decreased fractional excretion of sodium in the same
of Cleveland-Department of Surgery, 11100 Euclid Avenue, Lakeside
model [9, 10]. Once again, our localization studies place Building, 7th Floor, Cleveland, Ohio 44106, USA.
ET in a position in which it could directly exert these
physiologic changes.
APPENDIXOne putative role for ET in the PTCN may be on the
recovery phase of ATN when epithelial cells regenerate Abbreviations used in this article are: ARF, acute renal failure;
ATN, acute tubular necrosis; DPBS, Dulbecco’s phosphate-bufferedand renal function returns. ET-1 is known to be a potent
saline; DU, densitometric unit; ET, endothelin; GFR, glomerular fil-
mitogen for several types of renal cells. Ong et al showed tration rate; I/R, ischemia/reperfusion; ppET-1, preproendothelin-1;
PTCN, peritubular capillary network; RT-PCR, reverse transcription-that hypoxia induces ET-1 gene up-regulation and that
polymerase chain reaction.the ET-1 peptide subsequently produced was able to act
as an autocrine growth factor in human proximal tubular
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